P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings
(2023)
Presentation / Conference
Hall, P., Howell, S., Venkitaraman, R., Thomson, A., Raja, F., King, J., …Kane, N. (2023, March). P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings. Poster presented at 18th St. Gallen International Breast Cancer Conference, Vienna, Austria